Company Overview of vasopharm GmbH
vasopharm GmbH, a pharmaceutical company, engages in the discovery and development of therapeutics for the treatment of cerebro and cardiovascular diseases, and their consequences. Its therapeutic pipeline VAS203, an allosteric nitric oxide synthase inhibitor interacting with the BH4 binding site of the enzyme; and VAS2870, a NAD(P)H oxidase (NOX) modulator for the treatment of peripheral arterial occlusive diseases. The company was founded in 1998 and is based in Wuerzburg, Germany.
Founded in 1998
49 931 35 90 99 0
49 931 35 90 99 12
Key Executives for vasopharm GmbH
vasopharm GmbH Key Developments
Similar Private Companies By Industry
|cell pharm Gesellschaft für pharmazeutische und diagnostische Präparate mbH||Europe|
|Lilly Pharma Holding Gmbh||Europe|
|Resolute Oncology GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact vasopharm GmbH, please visit www.vasopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.